Atlas Trials

Randomized Trial Comparing Sirolimus and Tacrolimus Versus Cyclosporine and Methotrexate as Graft-versus-host Disease (GVHD) Prophylaxis After Allogeneic Stem Cell Transplantation

Clinical trial NCT00993343 · COMPLETED

Trial details

NCT number
NCT00993343
Sponsor
Karolinska Institutet
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Graft-versus-host DiseaseSurvival
Start date
2007-09-01
Primary completion
2015-02-01
Enrollment
215

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.